TREATMENT FOR SUBSTANCE ABUSE Sample Clauses

TREATMENT FOR SUBSTANCE ABUSE. Employees who feel they may have a substance abuse problem are encouraged to voluntarily seek help by using the Employee Assistance Program (EAP) before alcohol and/or drug use lead to disciplinary action or termination. If an employee seeks help, he/she will be granted necessary disability leave of absence, if necessary, to receive the recommended treatment. Leaves of Absence associated with a just cause on the job injury or accident where an employee seeks treatment will not exceed two (2) times during an employee’s employment. No employee will have his job security or promotional opportunities jeopardized by his voluntary request for help. Any and all information surrounding a voluntary request and subsequent treatment by an employer will be kept strictly confidential. Employees who return to work from a disability leave of absence for treatment will be required to submit to a drug and alcohol test prior to being reinstated. If the test results are positive an employee will not be returned to work until he/she tests negative. If it is determined, as a result of positive test results, that an employee violated this policy, a meeting will take place between Human Resources, the Union, and the employee. The employee will be offered the option of seeking rehabilitation through referral as defined in this policy. If the employee enters and successfully completes a treatment program, he/she will be required to pass a urinalysis or breathalyzer test prior to returning to work and must agree to random testing for the next 12 months. Tests will be conducted not more than four (4) times in a twelve (12) month period. If the employee refuses this option, he/she may be subject to disciplinary action up to and including termination. Subsequent violation of this policy by an employee based on positive test results may subject the employee to disciplinary action up to and including termination. Despite the foregoing, the Company reserves the right to discipline or discharge any employee who tests positive on a drug and alcohol test if the employee’s conduct that precipitated the test is otherwise sufficiently serious to warrant discipline or discharge. Union Company Date Date ATTACHMENT A The following statement must be read by the supervisor/member of management to the associate before he/she is sent to the clinic for drug/alcohol examination and signed by the supervisor and a witness: “You are being sent to the Sandusky Medical Clinic (as defined by the Company) bec...
AutoNDA by SimpleDocs
TREATMENT FOR SUBSTANCE ABUSE. Successful treatment of substance abuse is, to a great degree, dependent upon the desire of the abuser to overcome the disease and his/her willingness to seek proper treatment. The Company encourages voluntary drug or alcohol abuse treatment and will be supportive of employees and/or their dependents who seek treatment of their own accord. Conversely, the Company will take strong action against those employees who suffer from drug or alcohol abuse, but who refuse to seek treatment for the problem. -------------------------------------------------------------------------------- If an employee tests positive for drugs or alcohol after being referred for mandatory testing because of declining job performance or erratic on-the-job behavior, that employee is in violation of the Company's Alcohol and Drug Abuse Policy. Any employee who has reason to suspect another employee or supervisor may be abusing drugs or alcohol is encouraged to contact the Company's program administrator, who will evaluate the situation and determine what steps should be taken. Employees can be assured they may take such action on a confidential basis and without fear of reprisal.

Related to TREATMENT FOR SUBSTANCE ABUSE

  • Environment, Health, and Safety 24.4.1. The Supplier and its staff (and/or any sub-supplier and/or subcontractor) shall comply with the laws and regulations in force related to protection of the environment, the health and safety instructions applicable to the Goods and Services performed pursuant to the Contract and especially, if appropriate, to the Goodsand Services performedon any Site by a third company.

  • Definition of Hazardous Materials For purposes of this Lease, the term “Hazardous Material” or “Hazardous Materials” shall mean any hazardous or toxic substance, material, product, byproduct, or waste, which is or shall become regulated by any governmental entity, including, without limitation, the County acting in its governmental capacity, the State of California or the United States government.

  • Payment for Labor and Materials The Contractor agrees and binds itself to pay for all labor done, and for all the materials used in the construction of the work to be completed pursuant to this contract.

  • Environmental, Health and Safety i. Environment, Health and Safety Performance. Seller acknowledges and accepts full and sole responsibility to maintain an environment, health and safety management system ("EMS") appropriate for its business throughout the performance of this Contract. Buyer expects that Seller’s EMS shall promote health and safety, environmental stewardship, and pollution prevention by appropriate source reduction strategies. Seller shall convey the requirement of this clause to its suppliers. Seller shall not deliver goods that contain asbestos mineral fibers.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • ANALYSIS AND MONITORING The Custodian shall (a) provide the Fund (or its duly-authorized investment manager or investment adviser) with an analysis of the custody risks associated with maintaining assets with the Eligible Securities Depositories set forth on Schedule B hereto in accordance with section (a)(1)(i)(A) of Rule 17f-7, and (b) monitor such risks on a continuing basis, and promptly notify the Fund (or its duly-authorized investment manager or investment adviser) of any material change in such risks, in accordance with section (a)(1)(i)(B) of Rule 17f-7.

  • Environmental, Health and Safety Matters (a) The Company has complied and is in compliance with all Environmental, Health, and Safety Requirements.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Payment for Improvements If payment is made directly to contractors, Tenant shall (i) comply with Landlord's requirements for final lien releases and waivers in connection with Tenant's payment for work to contractors, and (ii) sign Landlord's standard contractor's rules and regulations. If Tenant orders any work directly from Landlord, Tenant shall pay to Landlord an amount equal to five percent of the cost of such work to compensate Landlord for all overhead, general conditions, fees and other costs and expenses arising from Landlord's involvement with such work. If Tenant does not order any work directly from Landlord, Tenant shall reimburse Landlord for Landlord's reasonable, actual, out-of-pocket costs and expenses actually incurred in connection with Landlord's review of such work.

Time is Money Join Law Insider Premium to draft better contracts faster.